These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26604924)

  • 1. Galectin-3 and Cyclin D3 Immunohistochemistry and Tumor Dimensions Are Useful in Distinguishing Follicular Oncocytic Carcinomas from Oncocytic Adenomas of the Thyroid.
    Cacchi C; Arnholdt HM; Haas CJ; Kretsinger H; Axt L; Märkl B
    Int J Endocrinol; 2015; 2015():276854. PubMed ID: 26604924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of galectin-3 and thyroid peroxidase improves the differential diagnosis of thyroid tumors.
    Kalfert D; Ludvikova M; Kholova I; Ludvik J; Topolocan O; Plzak J
    Neoplasma; 2020 Jan; 67(1):164-170. PubMed ID: 31777257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of CD15, galectin-3 and HBME-1 expression in follicular thyroid neoplasms].
    Bogdańska M; Górnicka B; Ziarkiewicz-Wróblewska B; Koperski L; Morton M; Wasiutyński A
    Endokrynol Pol; 2006; 57(4):314-9. PubMed ID: 17006830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid.
    Volante M; Bozzalla-Cassione F; DePompa R; Saggiorato E; Bartolazzi A; Orlandi F; Papotti M
    Virchows Arch; 2004 Aug; 445(2):183-8. PubMed ID: 15252732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.
    Hooft L; van der Veldt AA; Hoekstra OS; Boers M; Molthoff CF; van Diest PJ
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):252-7. PubMed ID: 17868400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
    Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
    Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hürthle Cell Adenomas and Carcinomas).
    Monaco M; Chiappetta G; Aiello C; Federico A; Sepe R; Russo D; Fusco A; Pallante P
    Eur Thyroid J; 2014 Dec; 3(4):211-6. PubMed ID: 25759796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
    Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of immunohistochemical expression of p27 and galectin-3 in differentiation between follicular adenoma and follicular carcinoma.
    Abulkheir IL; Mohammad DB
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):131-40. PubMed ID: 22553813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules.
    Beesley MF; McLaren KM
    Histopathology; 2002 Sep; 41(3):236-43. PubMed ID: 12207785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor.
    Cui W; Lu X; Zheng S; Ma Y; Liu X; Zhang W
    Clin Lab; 2012; 58(5-6):419-26. PubMed ID: 22783570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
    Murtezaoglu AR; Gucer H
    Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
    Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative markers in diagnosis of thyroid tumors: a comparative study of MIB-1 and topoisomerase II-a immunostaining.
    Ludvíková M; Holubec L; Ryska A; Topolcan O
    Anticancer Res; 2005; 25(3A):1835-40. PubMed ID: 16033110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Askenazi (Hurtle) cell tumors of the thyroid].
    Raĭkhlin NT; Smirnova EA; Pavlovskaia AI; Rotin DL; Gurevich LE; Savelov NA
    Arkh Patol; 2005; 67(6):13-6. PubMed ID: 16405013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late bone metastasis from an apparently benign oncocytic follicular thyroid tumor.
    Boronat M; Cabrera JJ; Perera C; Isla C; Nóvoa FJ
    Endocrinol Diabetes Metab Case Rep; 2013; 2013():130051. PubMed ID: 24616777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.